TY - JOUR
T1 - Super-sensitive time-resolved fluoroimmunoassay for thyroid-stimulating hormone utilizing europium(III) nanoparticle labels achieved by protein corona stabilization, short binding time, and serum preprocessing
AU - Näreoja, T
AU - Rosenholm, Jessica
AU - Lamminmäki, U
AU - Hänninen, PE
PY - 2017
Y1 - 2017
N2 - Thyrotropin or thyroid-stimulating hormone (TSH) is used as a marker for thyroid function. More precise and more sensitive immunoassays are needed to facilitate continuous monitoring of thyroid dysfunctions and to assess the efficacy of the selected therapy and dosage of medication. Moreover, most thyroid diseases are autoimmune diseases making TSH assays very prone to immunoassay interferences due to autoantibodies in the sample matrix. We have developed a super-sensitive TSH immunoassay utilizing nanoparticle labels with a detection limit of 60 nU L-1 in preprocessed serum samples by reducing nonspecific binding. The developed preprocessing step by affinity purification removed interfering compounds and improved the recovery of spiked TSH from serum. The sensitivity enhancement was achieved by stabilization of the protein corona of the nanoparticle bioconjugates and a spot-coated configuration of the active solid-phase that reduced sedimentation of the nanoparticle bioconjugates and their contact time with antibody-coated solid phase, thus making use of the higher association rate of specific binding due to high avidity nanoparticle bioconjugates.
AB - Thyrotropin or thyroid-stimulating hormone (TSH) is used as a marker for thyroid function. More precise and more sensitive immunoassays are needed to facilitate continuous monitoring of thyroid dysfunctions and to assess the efficacy of the selected therapy and dosage of medication. Moreover, most thyroid diseases are autoimmune diseases making TSH assays very prone to immunoassay interferences due to autoantibodies in the sample matrix. We have developed a super-sensitive TSH immunoassay utilizing nanoparticle labels with a detection limit of 60 nU L-1 in preprocessed serum samples by reducing nonspecific binding. The developed preprocessing step by affinity purification removed interfering compounds and improved the recovery of spiked TSH from serum. The sensitivity enhancement was achieved by stabilization of the protein corona of the nanoparticle bioconjugates and a spot-coated configuration of the active solid-phase that reduced sedimentation of the nanoparticle bioconjugates and their contact time with antibody-coated solid phase, thus making use of the higher association rate of specific binding due to high avidity nanoparticle bioconjugates.
KW - time-resolved fluoroimmunoassay
KW - Sandwich-type immunoassay
KW - Nanoparticle bioconjugate
KW - Immunoassay interference
KW - Nanoparticle protein corona
KW - time-resolved fluoroimmunoassay
KW - Sandwich-type immunoassay
KW - Nanoparticle bioconjugate
KW - Immunoassay interference
KW - Nanoparticle protein corona
KW - time-resolved fluoroimmunoassay
KW - Sandwich-type immunoassay
KW - Nanoparticle bioconjugate
KW - Immunoassay interference
KW - Nanoparticle protein corona
U2 - 10.1007/s00216-017-0284-z
DO - 10.1007/s00216-017-0284-z
M3 - Artikel
SN - 1618-2642
VL - 409
SP - 3407
EP - 3416
JO - Analytical and Bioanalytical Chemistry
JF - Analytical and Bioanalytical Chemistry
IS - 13
ER -